$CYTR: Yes. Thanks for asking. Hope everything is good with all of you here. Make sure you keep eye on biotech $CYTR which has drugs for cancer treatment in phase 2 & 3. Their drug is so effective that FDA already approved the use on hundreds of patients.
3 Analysts just have given the stock a near short term price target of $9.33 and currently it is at $3.90. GLTA